Dendritic cells as natural adjuvants

被引:20
|
作者
Citterio, S
Rescigno, M
Foti, M
Granucci, F
Aggujaro, D
Gasperi, C
Matyszak, MK
Girolomoni, G
Ricciardi-Castagnoli, P [1 ]
机构
[1] Univ Milan, CNR, Cellular & Mol Pharmacol Ctr, Dept Biotechnol & Biol Sci, I-20129 Milan, Italy
[2] IRCCS, Immunol Lab, Ist Dermopat Immacolata, Rome, Italy
来源
关键词
D O I
10.1006/meth.1999.0839
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Dendritic cells (DCs) are professional antigen presenting cells that hold the hey to the induction of T-cell responses. Therefore, the use of DCs for immunotherapy to stimulate immune responses has recently raised a great deal of interest. Many clinical trials using DCs have been initiated to stimulate immune responses against tumors or infectious agents. Several issues need to be considered before DCs can be used successfully as natural adjuvants: DCs have to be generated in sufficient numbers; they should display morphological, phenotypical, and functional properties of DCs; and they should be able to present antigens. In the present review we focus on methods for the purification of DCs from human bone marrow and peripheral blood and for the optimization of in vitro cell culture systems. Methods to generate growth factor-dependent mouse DC lines are also described. (C) 1999 Academic Press.
引用
收藏
页码:142 / 147
页数:6
相关论文
共 50 条
  • [1] Natural adjuvants: Endogenous activators of dendritic cells
    Stefania Gallucci
    Martijn Lolkema
    Polly Matzinger
    [J]. Nature Medicine, 1999, 5 : 1249 - 1255
  • [2] Natural adjuvants: Endogenous activators of dendritic cells
    Gallucci, S
    Lolkema, M
    Matzinger, P
    [J]. NATURE MEDICINE, 1999, 5 (11) : 1249 - 1255
  • [3] Human dendritic cells: natural adjuvants in antitumor immunotherapy
    Di Nicola, M
    Anichini, A
    Mortarini, R
    Bregni, M
    Parmiani, G
    Gianni, AM
    [J]. CYTOKINES CELLULAR & MOLECULAR THERAPY, 1998, 4 (04) : 265 - 273
  • [4] Dendritic cells as natural adjuvants and modulators of immune response in cancer immunotherapy
    Alli, RS
    Khar, A
    [J]. INDIAN JOURNAL OF BIOCHEMISTRY & BIOPHYSICS, 2002, 39 (06): : 363 - 367
  • [5] Dendritic cells as immunologic adjuvants for the treatment of cancer
    Baggers, J
    Ratzinger, G
    Young, JW
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (23) : 3879 - 3882
  • [6] Dendritic cells as adjuvants in antitumor immune therapy
    Felzmann, T
    Gadner, H
    Holter, W
    [J]. ONKOLOGIE, 2002, 25 (05): : 456 - 464
  • [7] Activation of tonsil dendritic cells with immuno-adjuvants
    Polak, Marta E.
    Borthwick, Nicola J.
    Gabriel, Francis G.
    Jager, Martine J.
    Cree, Ian A.
    [J]. BMC IMMUNOLOGY, 2008, 9 (1)
  • [8] Activation of tonsil dendritic cells with immuno-adjuvants
    Marta E Polak
    Nicola J Borthwick
    Francis G Gabriel
    Martine J Jager
    Ian A Cree
    [J]. BMC Immunology, 9
  • [9] Specific adjuvants prime dendritic cells to induce regulatory T cells
    Sibiryak, D.
    van Capel, T.
    Kapsenberg, M.
    de Jong, E.
    [J]. ALLERGY, 2008, 63 : 144 - 144
  • [10] Dendritic cells as adjuvants for immune-mediated resistance to tumors
    Schuler, G
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1999, 113 (03) : 517 - 517